Vertex Pharmaceuticals

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$377.85-$519.88
Market Cap
$131.4B
Shares Short
5M

Financials

See more
Revenue (12 Mos)
$11B
Revenue Growth (YoY)
15.7%
Gross Profit (12 Mos)
$6B
Diluted EPS
-$2.09

News

See more

Yahoo Finance • 3 days ago

Jim Cramer on Vertex (VRTX): “A Revolutionary Anti-Pain Drug”

Yahoo Finance • 9 days ago

3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Yahoo Finance • 14 days ago

Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?

Yahoo Finance • 19 days ago

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

About

CEO
Dr. Reshma Kewalramani FASN, M.D.
CFO
Mr. Charles F. Wagner Jr.
Address
50 Northern Avenue, Boston, MA, United States, 02210
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
6,100